PAD undergoes aberrant exposure during early disease stages in tauopathies, in a manner concomitant with progressive tau aggregation and phosphorylation at the AT8 epitope (Kanaan et al., 2011, 2016; Combs et al., 2016). Here, MAPT is linked to tauopathy.